Company
Drugs Made In America Acquisition II Corp. (DMII)
Standardized SEC financial data for Drugs Made In America Acquisition II Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0002040475 · NASDAQ · Blank Checks.
Return on equity
-23.6%
Free cash flow
-$1.0M
Current ratio
0.09×
Income statement
| USD | FY2025 |
|---|---|
| SG&A expense | $488K |
| Operating income | -$488K |
| Net income | $4.2M |
Standardized from Drugs Made In America Acquisition II Corp.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2024 | FY2025 |
|---|---|---|
| Cash & equivalents | $17K | $223 |
| Total current assets | $60K | $26K |
| Total assets | $138K | $505.0M |
| Total current liabilities | $255K |
Cash flow
| USD | FY2025 |
|---|---|
| Operating cash flow | -$1.0M |
| Investing cash flow | -$500.0M |
| Financing cash flow | $501.0M |
| Dividends paid | $0 |
Get DMII data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/DMII/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/DMII/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"